Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf1
|
ENSMUSG00000036461.9 | E74-like factor 1 |
Elf2
|
ENSMUSG00000037174.12 | E74-like factor 2 |
Etv2
|
ENSMUSG00000006311.8 | ets variant 2 |
Elf4
|
ENSMUSG00000031103.6 | E74-like factor 4 (ets domain transcription factor) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_79508533_79508702 | Elf1 | 7057 | 0.168225 | -0.85 | 3.4e-02 | Click! |
chr14_79512054_79512205 | Elf1 | 3545 | 0.204762 | 0.85 | 3.4e-02 | Click! |
chr14_79509030_79509204 | Elf1 | 6557 | 0.170616 | 0.82 | 4.4e-02 | Click! |
chr14_79515540_79515738 | Elf1 | 35 | 0.973275 | 0.79 | 6.0e-02 | Click! |
chr14_79535421_79535592 | Elf1 | 19808 | 0.143774 | 0.72 | 1.0e-01 | Click! |
chr3_51341587_51341738 | Elf2 | 999 | 0.398158 | -0.89 | 1.6e-02 | Click! |
chr3_51256576_51256727 | Elf2 | 3590 | 0.155026 | -0.86 | 2.7e-02 | Click! |
chr3_51278358_51278509 | Elf2 | 858 | 0.425350 | -0.86 | 3.0e-02 | Click! |
chr3_51255928_51256079 | Elf2 | 4238 | 0.145380 | -0.85 | 3.3e-02 | Click! |
chr3_51253917_51254078 | Elf2 | 6244 | 0.131410 | -0.84 | 3.8e-02 | Click! |
chrX_48423070_48423233 | Elf4 | 31018 | 0.146965 | -0.74 | 9.2e-02 | Click! |
chrX_48424724_48424883 | Elf4 | 29366 | 0.150852 | 0.70 | 1.2e-01 | Click! |
chrX_48462781_48462950 | Elf4 | 267 | 0.913369 | 0.07 | 8.9e-01 | Click! |
chr7_30634719_30634913 | Etv2 | 1036 | 0.238807 | -0.24 | 6.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_71235183_71235374 | 6.11 |
Smyd1 |
SET and MYND domain containing 1 |
18404 |
0.1 |
chr5_129260831_129260994 | 5.53 |
Gm43001 |
predicted gene 43001 |
102650 |
0.07 |
chr1_181345585_181345736 | 4.52 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
6968 |
0.18 |
chr6_91972206_91972611 | 4.51 |
Fgd5 |
FYVE, RhoGEF and PH domain containing 5 |
6470 |
0.15 |
chr11_98767399_98767584 | 4.25 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
2935 |
0.14 |
chr16_77569572_77569736 | 4.15 |
Gm37606 |
predicted gene, 37606 |
8004 |
0.11 |
chr10_20241060_20241211 | 4.14 |
Map7 |
microtubule-associated protein 7 |
11340 |
0.14 |
chr15_98484617_98484776 | 4.13 |
Lalba |
lactalbumin, alpha |
1975 |
0.14 |
chr7_140771376_140771879 | 4.12 |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
7146 |
0.09 |
chr1_194652069_194652379 | 4.07 |
Gm37783 |
predicted gene, 37783 |
1905 |
0.29 |
chr7_140770591_140771104 | 4.04 |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
6366 |
0.09 |
chr18_81199291_81199673 | 4.00 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
36584 |
0.17 |
chr7_83842916_83843186 | 4.00 |
Gm44993 |
predicted gene 44993 |
8452 |
0.11 |
chr2_84184780_84185142 | 3.98 |
Gm25972 |
predicted gene, 25972 |
34906 |
0.15 |
chr11_49632419_49632570 | 3.82 |
Flt4 |
FMS-like tyrosine kinase 4 |
23231 |
0.1 |
chr16_95449403_95449694 | 3.80 |
Erg |
ETS transcription factor |
9697 |
0.27 |
chr10_77480104_77480271 | 3.78 |
Gm35920 |
predicted gene, 35920 |
22270 |
0.13 |
chr12_111382038_111382189 | 3.72 |
Cdc42bpb |
CDC42 binding protein kinase beta |
4395 |
0.16 |
chr4_139301929_139302115 | 3.69 |
Pqlc2 |
PQ loop repeat containing 2 |
8615 |
0.1 |
chr17_29465506_29465692 | 3.69 |
Gm26885 |
predicted gene, 26885 |
399 |
0.53 |
chr7_109023628_109024018 | 3.67 |
Tub |
tubby bipartite transcription factor |
3400 |
0.21 |
chr14_22269831_22270192 | 3.66 |
Lrmda |
leucine rich melanocyte differentiation associated |
40154 |
0.2 |
chr3_90446574_90447024 | 3.62 |
Gm16048 |
predicted gene 16048 |
4784 |
0.1 |
chr16_91916614_91917006 | 3.59 |
Gm25245 |
predicted gene, 25245 |
4605 |
0.12 |
chr10_77434519_77434733 | 3.55 |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
16356 |
0.16 |
chr2_124555012_124555366 | 3.55 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
54917 |
0.17 |
chr1_137074836_137075091 | 3.54 |
Gm23763 |
predicted gene, 23763 |
84693 |
0.09 |
chr15_28106057_28106225 | 3.53 |
Gm31458 |
predicted gene, 31458 |
12311 |
0.17 |
chr5_99362991_99363432 | 3.52 |
Gm35394 |
predicted gene, 35394 |
89116 |
0.08 |
chr1_39731626_39731803 | 3.51 |
Rfx8 |
regulatory factor X 8 |
10717 |
0.2 |
chr17_29502998_29503149 | 3.51 |
Pim1 |
proviral integration site 1 |
9666 |
0.1 |
chr8_105727451_105727631 | 3.46 |
4933405L10Rik |
RIKEN cDNA 4933405L10 gene |
19238 |
0.08 |
chr1_119289922_119290107 | 3.46 |
Gm29456 |
predicted gene 29456 |
36819 |
0.14 |
chr19_40840384_40840634 | 3.45 |
Ccnj |
cyclin J |
9201 |
0.17 |
chr15_89497756_89497950 | 3.45 |
Gm41381 |
predicted gene, 41381 |
96 |
0.93 |
chr2_129129602_129129765 | 3.44 |
Chchd5 |
coiled-coil-helix-coiled-coil-helix domain containing 5 |
17 |
0.96 |
chrX_12129323_12129512 | 3.44 |
Bcor |
BCL6 interacting corepressor |
1017 |
0.64 |
chr4_102045640_102046043 | 3.43 |
Gm12799 |
predicted gene 12799 |
3286 |
0.25 |
chr2_152686932_152687103 | 3.42 |
Mcts2 |
malignant T cell amplified sequence 2 |
18 |
0.95 |
chr14_25401582_25402102 | 3.41 |
Gm26660 |
predicted gene, 26660 |
22233 |
0.15 |
chr3_84582502_84582696 | 3.41 |
Arfip1 |
ADP-ribosylation factor interacting protein 1 |
26 |
0.97 |
chr8_114815443_114815594 | 3.39 |
Wwox |
WW domain-containing oxidoreductase |
103351 |
0.07 |
chr1_173802690_173802855 | 3.38 |
Ifi203-ps |
interferon activated gene 203, pseudogene |
4502 |
0.15 |
chr2_114782498_114782839 | 3.34 |
Gm13974 |
predicted gene 13974 |
71425 |
0.1 |
chr4_95354053_95354288 | 3.34 |
Gm29064 |
predicted gene 29064 |
48620 |
0.15 |
chr16_28984783_28985218 | 3.33 |
Gm8253 |
predicted gene 8253 |
33645 |
0.21 |
chr17_83977798_83977969 | 3.30 |
Gm41638 |
predicted gene, 41638 |
16953 |
0.1 |
chr7_101074319_101074575 | 3.30 |
Gm5735 |
predicted gene 5735 |
12972 |
0.15 |
chr13_112753469_112753867 | 3.29 |
Gm47850 |
predicted gene, 47850 |
11180 |
0.15 |
chr19_7400740_7400902 | 3.29 |
Rab11b-ps2 |
RAB11B, member RAS oncogene family, pseudogene 2 |
1744 |
0.19 |
chr18_74624820_74624979 | 3.29 |
Myo5b |
myosin VB |
8278 |
0.25 |
chr14_20693519_20693705 | 3.28 |
Fut11 |
fucosyltransferase 11 |
1356 |
0.19 |
chr10_77904908_77905098 | 3.28 |
Lrrc3 |
leucine rich repeat containing 3 |
2467 |
0.12 |
chr5_76013943_76014156 | 3.27 |
Gm24738 |
predicted gene, 24738 |
7608 |
0.17 |
chr2_26578415_26578758 | 3.27 |
Egfl7 |
EGF-like domain 7 |
1428 |
0.23 |
chr1_185587723_185587874 | 3.26 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
90410 |
0.07 |
chr17_27480362_27480514 | 3.26 |
Grm4 |
glutamate receptor, metabotropic 4 |
7122 |
0.11 |
chr4_99152254_99152434 | 3.24 |
Gm12681 |
predicted gene 12681 |
9298 |
0.16 |
chr7_71233219_71233391 | 3.23 |
6030442E23Rik |
RIKEN cDNA 6030442E23 gene |
16256 |
0.2 |
chr9_107628752_107629042 | 3.22 |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
2291 |
0.11 |
chr10_10396185_10396349 | 3.22 |
Adgb |
androglobin |
15477 |
0.2 |
chr12_26367487_26367659 | 3.21 |
4930549C15Rik |
RIKEN cDNA 4930549C15 gene |
20856 |
0.16 |
chr17_67512799_67512950 | 3.20 |
Gm36201 |
predicted gene, 36201 |
116458 |
0.06 |
chr5_115882251_115882451 | 3.20 |
Cit |
citron |
4067 |
0.19 |
chr12_5213695_5213866 | 3.20 |
Gm48532 |
predicted gene, 48532 |
22184 |
0.23 |
chr1_88635717_88635891 | 3.19 |
Gm38130 |
predicted gene, 38130 |
17281 |
0.16 |
chr15_7201002_7201153 | 3.19 |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
21992 |
0.23 |
chr5_114806082_114806287 | 3.19 |
Ankrd13a |
ankyrin repeat domain 13a |
6613 |
0.09 |
chr7_98077544_98077739 | 3.18 |
Myo7a |
myosin VIIA |
7078 |
0.22 |
chr8_119443770_119443946 | 3.12 |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
2861 |
0.21 |
chr12_25132357_25132520 | 3.12 |
Gm17746 |
predicted gene, 17746 |
3264 |
0.21 |
chr11_106967758_106967936 | 3.12 |
Gm11707 |
predicted gene 11707 |
5243 |
0.15 |
chr1_40221808_40222119 | 3.11 |
Il1r1 |
interleukin 1 receptor, type I |
3117 |
0.26 |
chr6_115971312_115971488 | 3.09 |
Plxnd1 |
plexin D1 |
1974 |
0.25 |
chr15_82290409_82290560 | 3.09 |
Septin3 |
septin 3 |
6054 |
0.09 |
chr11_107529428_107529614 | 3.09 |
C330019F10Rik |
RIKEN cDNA C330019F10 gene |
2301 |
0.19 |
chr13_38593226_38593439 | 3.08 |
Gm40922 |
predicted gene, 40922 |
38467 |
0.09 |
chr19_21127500_21127667 | 3.08 |
4930554I06Rik |
RIKEN cDNA 4930554I06 gene |
22873 |
0.2 |
chr12_24463539_24463734 | 3.07 |
Gm16372 |
predicted pseudogene 16372 |
30020 |
0.14 |
chr1_171565956_171566129 | 3.06 |
Cd244a |
CD244 molecule A |
6848 |
0.1 |
chr6_72617525_72617676 | 3.06 |
Tgoln1 |
trans-golgi network protein |
600 |
0.51 |
chr5_138105081_138105232 | 3.06 |
Gm43493 |
predicted gene 43493 |
1751 |
0.17 |
chr2_84386945_84387393 | 3.06 |
Calcrl |
calcitonin receptor-like |
11811 |
0.2 |
chr13_52060383_52060534 | 3.05 |
Gm48190 |
predicted gene, 48190 |
36184 |
0.14 |
chr8_128437574_128437770 | 3.05 |
Nrp1 |
neuropilin 1 |
78275 |
0.1 |
chr6_35874026_35874908 | 3.05 |
Gm43442 |
predicted gene 43442 |
52244 |
0.17 |
chr10_99384294_99384806 | 3.05 |
B530045E10Rik |
RIKEN cDNA B530045E10 gene |
18240 |
0.17 |
chr13_37751617_37751789 | 3.05 |
Gm31600 |
predicted gene, 31600 |
10045 |
0.14 |
chr17_47295314_47295504 | 3.05 |
Trerf1 |
transcriptional regulating factor 1 |
1340 |
0.4 |
chr9_26923072_26923237 | 3.04 |
Gm1110 |
predicted gene 1110 |
43 |
0.97 |
chr2_24311684_24311860 | 3.04 |
Gm13411 |
predicted gene 13411 |
10652 |
0.12 |
chr10_8193600_8193751 | 3.04 |
Gm30906 |
predicted gene, 30906 |
17544 |
0.26 |
chr17_5794541_5794694 | 3.03 |
3300005D01Rik |
RIKEN cDNA 3300005D01 gene |
4040 |
0.19 |
chr17_88341719_88341880 | 3.02 |
Gm22542 |
predicted gene, 22542 |
683 |
0.69 |
chr4_129572372_129572571 | 3.02 |
Lck |
lymphocyte protein tyrosine kinase |
1170 |
0.26 |
chr7_66623439_66623745 | 2.99 |
Gm44610 |
predicted gene 44610 |
4444 |
0.19 |
chr9_102709863_102710063 | 2.98 |
Amotl2 |
angiomotin-like 2 |
6709 |
0.13 |
chr11_22780285_22780446 | 2.96 |
Gm12058 |
predicted gene 12058 |
6882 |
0.15 |
chr7_48899148_48899299 | 2.94 |
Gm2788 |
predicted gene 2788 |
416 |
0.77 |
chr10_4107762_4107973 | 2.94 |
Gm25515 |
predicted gene, 25515 |
3554 |
0.27 |
chr10_75835778_75835936 | 2.93 |
Gstt2 |
glutathione S-transferase, theta 2 |
976 |
0.36 |
chr3_145834049_145834216 | 2.93 |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
23653 |
0.18 |
chr5_148741720_148741892 | 2.92 |
2210417A02Rik |
RIKEN cDNA 2210417A02 gene |
34 |
0.97 |
chr4_123427592_123427944 | 2.92 |
Gm12924 |
predicted gene 12924 |
7849 |
0.18 |
chr11_114868321_114868609 | 2.91 |
Gprc5c |
G protein-coupled receptor, family C, group 5, member C |
3973 |
0.16 |
chr4_150858687_150859936 | 2.91 |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
4238 |
0.16 |
chr11_72458057_72458494 | 2.90 |
Spns2 |
spinster homolog 2 |
1654 |
0.27 |
chr12_110381296_110381622 | 2.88 |
Gm47195 |
predicted gene, 47195 |
56074 |
0.08 |
chr6_120479402_120479564 | 2.88 |
Il17ra |
interleukin 17 receptor A |
5880 |
0.14 |
chr8_83657002_83657190 | 2.87 |
Gipc1 |
GIPC PDZ domain containing family, member 1 |
4398 |
0.12 |
chr9_50471626_50471777 | 2.87 |
Plet1 |
placenta expressed transcript 1 |
22824 |
0.13 |
chr9_35039370_35039714 | 2.86 |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
16252 |
0.16 |
chr10_37711570_37711751 | 2.86 |
Gm24710 |
predicted gene, 24710 |
220020 |
0.02 |
chr9_32504129_32504422 | 2.86 |
Gm27201 |
predicted gene 27201 |
4138 |
0.14 |
chr3_101524513_101524690 | 2.85 |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
52959 |
0.11 |
chr9_32906562_32906941 | 2.84 |
Gm27162 |
predicted gene 27162 |
22215 |
0.19 |
chr1_172277255_172277406 | 2.84 |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
852 |
0.44 |
chr8_70634514_70634904 | 2.84 |
Gdf15 |
growth differentiation factor 15 |
2253 |
0.14 |
chr8_70777137_70777343 | 2.83 |
2010320M18Rik |
RIKEN cDNA 2010320M18 gene |
425 |
0.43 |
chr11_6478757_6478908 | 2.82 |
Purb |
purine rich element binding protein B |
2915 |
0.11 |
chr8_80952324_80952677 | 2.82 |
Gm27048 |
predicted gene, 27048 |
13833 |
0.16 |
chr19_29238295_29238505 | 2.82 |
Jak2 |
Janus kinase 2 |
13428 |
0.18 |
chr1_167356546_167356902 | 2.82 |
Aldh9a1 |
aldehyde dehydrogenase 9, subfamily A1 |
6412 |
0.13 |
chr18_74814892_74815080 | 2.80 |
Acaa2 |
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) |
21603 |
0.14 |
chr11_63988783_63989464 | 2.80 |
Gm12289 |
predicted gene 12289 |
23492 |
0.17 |
chr2_75564827_75565114 | 2.80 |
Gm13655 |
predicted gene 13655 |
68412 |
0.08 |
chr2_93892038_93892190 | 2.80 |
Accsl |
1-aminocyclopropane-1-carboxylate synthase (non-functional)-like |
22957 |
0.14 |
chr11_69849251_69849536 | 2.80 |
Plscr3 |
phospholipid scramblase 3 |
2717 |
0.08 |
chr16_11520908_11521091 | 2.80 |
Gm15897 |
predicted gene 15897 |
24693 |
0.22 |
chr2_180218772_180218969 | 2.79 |
Lama5 |
laminin, alpha 5 |
6989 |
0.13 |
chr10_94351045_94351228 | 2.78 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
38999 |
0.14 |
chr1_86858960_86859159 | 2.78 |
Dis3l2 |
DIS3 like 3'-5' exoribonuclease 2 |
1688 |
0.24 |
chr18_43360044_43360530 | 2.78 |
Dpysl3 |
dihydropyrimidinase-like 3 |
12936 |
0.23 |
chr19_57658273_57658440 | 2.78 |
Atrnl1 |
attractin like 1 |
47322 |
0.14 |
chr5_134572591_134572794 | 2.78 |
Mir7228 |
microRNA 7228 |
616 |
0.56 |
chr1_180354252_180354425 | 2.77 |
Gm37033 |
predicted gene, 37033 |
3311 |
0.17 |
chr8_117548542_117548713 | 2.77 |
Gm27361 |
predicted gene, 27361 |
1601 |
0.41 |
chr11_116435092_116435485 | 2.77 |
Ubald2 |
UBA-like domain containing 2 |
779 |
0.48 |
chr9_37362212_37362376 | 2.77 |
Hepacam |
hepatocyte cell adhesion molecule |
5057 |
0.12 |
chr15_75593070_75593251 | 2.77 |
Gpihbp1 |
GPI-anchored HDL-binding protein 1 |
3468 |
0.15 |
chr14_7990964_7991352 | 2.76 |
Dnase1l3 |
deoxyribonuclease 1-like 3 |
3415 |
0.22 |
chr2_32731742_32731919 | 2.75 |
6330409D20Rik |
RIKEN cDNA 6330409D20 gene |
3048 |
0.1 |
chr13_42565310_42565506 | 2.74 |
Gm47125 |
predicted gene, 47125 |
4055 |
0.29 |
chr2_151572056_151572207 | 2.73 |
Sdcbp2 |
syndecan binding protein (syntenin) 2 |
491 |
0.73 |
chr13_60897330_60897663 | 2.73 |
Ctla2b |
cytotoxic T lymphocyte-associated protein 2 beta |
49 |
0.89 |
chr11_55468108_55468290 | 2.73 |
G3bp1 |
GTPase activating protein (SH3 domain) binding protein 1 |
1486 |
0.25 |
chr10_80933569_80933752 | 2.73 |
Gadd45b |
growth arrest and DNA-damage-inducible 45 beta |
2848 |
0.13 |
chr5_139364533_139364950 | 2.73 |
Mir339 |
microRNA 339 |
5004 |
0.12 |
chr3_51712576_51712746 | 2.71 |
Gm10729 |
predicted gene 10729 |
18890 |
0.12 |
chr7_69472368_69472519 | 2.71 |
Gm38584 |
predicted gene, 38584 |
18358 |
0.17 |
chr7_69074762_69075237 | 2.71 |
Gm44691 |
predicted gene 44691 |
85595 |
0.09 |
chr3_129614294_129614614 | 2.71 |
Elovl6 |
ELOVL family member 6, elongation of long chain fatty acids (yeast) |
62074 |
0.08 |
chr6_59185430_59185581 | 2.71 |
Gm43905 |
predicted gene, 43905 |
7748 |
0.22 |
chr18_69782032_69782386 | 2.70 |
Tcf4 |
transcription factor 4 |
99829 |
0.07 |
chr17_22867078_22867262 | 2.70 |
Zfp945 |
zinc finger protein 945 |
36 |
0.97 |
chr6_100415485_100415639 | 2.70 |
Gm23234 |
predicted gene, 23234 |
79252 |
0.08 |
chr12_108761354_108761518 | 2.69 |
Gm33682 |
predicted gene, 33682 |
1534 |
0.25 |
chr4_136090324_136090475 | 2.69 |
Gm13009 |
predicted gene 13009 |
15427 |
0.12 |
chr17_58480911_58481322 | 2.69 |
Gm49848 |
predicted gene, 49848 |
18791 |
0.25 |
chr8_121351760_121351911 | 2.68 |
Gm26815 |
predicted gene, 26815 |
5001 |
0.24 |
chr14_41198259_41198468 | 2.68 |
Gm47114 |
predicted gene, 47114 |
6710 |
0.12 |
chr6_113326732_113326898 | 2.68 |
Gm15492 |
predicted gene 15492 |
68 |
0.61 |
chr7_27490840_27491009 | 2.68 |
Sertad1 |
SERTA domain containing 1 |
3549 |
0.11 |
chr15_97590730_97591033 | 2.67 |
Gm49506 |
predicted gene, 49506 |
32591 |
0.19 |
chr1_64374852_64375011 | 2.67 |
Gm25748 |
predicted gene, 25748 |
21403 |
0.21 |
chr12_21526957_21527150 | 2.67 |
Gm19196 |
predicted gene, 19196 |
16254 |
0.22 |
chr2_169008469_169008643 | 2.66 |
Gm9873 |
predicted gene 9873 |
11469 |
0.16 |
chr18_34865352_34865513 | 2.65 |
Egr1 |
early growth response 1 |
4225 |
0.16 |
chr12_79625723_79626115 | 2.64 |
Rad51b |
RAD51 paralog B |
298566 |
0.01 |
chr13_70653559_70653710 | 2.64 |
Gm36377 |
predicted gene, 36377 |
2153 |
0.24 |
chr16_22899411_22899617 | 2.64 |
Ahsg |
alpha-2-HS-glycoprotein |
4650 |
0.13 |
chr1_39710733_39710905 | 2.64 |
Rfx8 |
regulatory factor X 8 |
10178 |
0.19 |
chr12_85348430_85348753 | 2.63 |
Tmed10 |
transmembrane p24 trafficking protein 10 |
2329 |
0.17 |
chr12_84388969_84389249 | 2.63 |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
3699 |
0.14 |
chr19_36133150_36133315 | 2.62 |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
13133 |
0.19 |
chr8_71680518_71680684 | 2.62 |
Jak3 |
Janus kinase 3 |
2266 |
0.14 |
chr2_114175267_114175427 | 2.62 |
Aqr |
aquarius |
8 |
0.98 |
chr8_33885650_33885854 | 2.61 |
Gm26978 |
predicted gene, 26978 |
5 |
0.97 |
chr19_42610535_42610705 | 2.60 |
Loxl4 |
lysyl oxidase-like 4 |
2089 |
0.31 |
chrX_51018786_51019139 | 2.60 |
Rap2c |
RAP2C, member of RAS oncogene family |
944 |
0.61 |
chr5_129887229_129887536 | 2.60 |
Chchd2 |
coiled-coil-helix-coiled-coil-helix domain containing 2 |
88 |
0.93 |
chr19_49421746_49421913 | 2.60 |
Gm50444 |
predicted gene, 50444 |
132189 |
0.06 |
chr7_111726929_111727297 | 2.60 |
Galnt18 |
polypeptide N-acetylgalactosaminyltransferase 18 |
52864 |
0.15 |
chr10_23788329_23788480 | 2.59 |
Rps12 |
ribosomal protein S12 |
1129 |
0.3 |
chr10_118011983_118012189 | 2.58 |
Gm37852 |
predicted gene, 37852 |
7148 |
0.22 |
chr11_4984826_4985069 | 2.57 |
Ap1b1 |
adaptor protein complex AP-1, beta 1 subunit |
1877 |
0.26 |
chr12_28248819_28248987 | 2.57 |
Gm47872 |
predicted gene, 47872 |
50743 |
0.15 |
chr2_84666202_84666381 | 2.56 |
Selenoh |
selenoprotein H |
4363 |
0.09 |
chr7_140772355_140773139 | 2.55 |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
8266 |
0.09 |
chr15_36448460_36448611 | 2.55 |
Gm49224 |
predicted gene, 49224 |
11844 |
0.15 |
chr10_119063130_119063294 | 2.55 |
Gm33677 |
predicted gene, 33677 |
12713 |
0.14 |
chr13_56648096_56648259 | 2.54 |
Tgfbi |
transforming growth factor, beta induced |
16964 |
0.19 |
chr2_4570492_4570903 | 2.54 |
Frmd4a |
FERM domain containing 4A |
4521 |
0.23 |
chr16_65451003_65451154 | 2.53 |
Gm23659 |
predicted gene, 23659 |
18941 |
0.21 |
chr5_134437733_134437992 | 2.53 |
Gm26340 |
predicted gene, 26340 |
10712 |
0.11 |
chr9_32901306_32901512 | 2.53 |
Gm27162 |
predicted gene 27162 |
27557 |
0.18 |
chr4_62324909_62325088 | 2.53 |
Fkbp15 |
FK506 binding protein 15 |
7296 |
0.16 |
chr10_3696942_3697316 | 2.53 |
Plekhg1 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
43235 |
0.18 |
chr7_27232216_27232404 | 2.52 |
Coq8b |
coenzyme Q8B |
713 |
0.41 |
chr9_44568060_44568211 | 2.52 |
Cxcr5 |
chemokine (C-X-C motif) receptor 5 |
6258 |
0.08 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.4 | GO:0006868 | glutamine transport(GO:0006868) |
1.6 | 4.7 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.3 | 4.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.2 | 3.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.1 | 3.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
1.1 | 3.3 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
1.1 | 1.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
1.0 | 3.1 | GO:1903416 | response to glycoside(GO:1903416) |
1.0 | 5.1 | GO:0009115 | xanthine catabolic process(GO:0009115) |
1.0 | 4.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.0 | 1.0 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
1.0 | 4.0 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.0 | 3.0 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.0 | 2.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.0 | 2.9 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.9 | 0.9 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.9 | 2.8 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.9 | 2.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.9 | 2.8 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.9 | 3.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.9 | 2.7 | GO:0021564 | vagus nerve development(GO:0021564) |
0.9 | 3.7 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.9 | 2.7 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.9 | 2.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.9 | 2.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.9 | 2.6 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.9 | 6.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.9 | 8.7 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.9 | 4.3 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.9 | 2.6 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 2.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.8 | 0.8 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.8 | 3.3 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.8 | 5.7 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.8 | 4.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.8 | 3.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.8 | 2.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.8 | 2.4 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.8 | 3.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.8 | 3.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.8 | 3.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.8 | 2.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.8 | 7.8 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.8 | 3.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.8 | 0.8 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.8 | 2.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.8 | 0.8 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.7 | 2.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.7 | 3.7 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.7 | 3.7 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.7 | 3.0 | GO:0008228 | opsonization(GO:0008228) |
0.7 | 0.7 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.7 | 2.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.7 | 2.9 | GO:0051031 | tRNA transport(GO:0051031) |
0.7 | 2.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.7 | 1.4 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.7 | 4.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.7 | 2.1 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.7 | 5.0 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.7 | 1.4 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.7 | 0.7 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.7 | 0.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.7 | 3.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.7 | 2.1 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.7 | 2.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.7 | 2.8 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.7 | 0.7 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.7 | 2.8 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.7 | 2.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.7 | 4.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.7 | 2.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.7 | 0.7 | GO:0032439 | endosome localization(GO:0032439) |
0.7 | 2.0 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.7 | 2.7 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.7 | 4.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.7 | 2.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.7 | 3.3 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.7 | 2.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.7 | 2.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 0.7 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.7 | 0.7 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.6 | 2.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.6 | 0.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.6 | 1.9 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.6 | 1.9 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.6 | 1.9 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.6 | 1.9 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.6 | 1.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.6 | 1.9 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.6 | 0.6 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 2.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.6 | 3.1 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.6 | 7.9 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.6 | 1.8 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.6 | 1.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.6 | 6.7 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.6 | 1.2 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.6 | 3.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 1.2 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.6 | 2.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.6 | 2.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.6 | 2.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.6 | 3.0 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.6 | 2.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.6 | 1.2 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.6 | 1.8 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.6 | 5.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.6 | 1.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.6 | 1.7 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.6 | 0.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.6 | 1.7 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.6 | 1.7 | GO:0050904 | diapedesis(GO:0050904) |
0.6 | 0.6 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.6 | 0.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.6 | 2.8 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.6 | 0.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.6 | 1.1 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.6 | 3.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.6 | 1.1 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.6 | 0.6 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.6 | 1.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.6 | 2.8 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.6 | 3.9 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.5 | 1.6 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.5 | 2.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.5 | 1.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 7.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.5 | 1.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 1.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.5 | 3.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.5 | 1.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.5 | 1.1 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.5 | 2.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.5 | 2.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.5 | 0.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.5 | 3.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.5 | 0.5 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.5 | 1.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 1.0 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.5 | 1.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.5 | 1.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.5 | 2.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 0.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.5 | 2.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.5 | 1.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.5 | 1.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.5 | 1.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.5 | 3.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.5 | 5.9 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.5 | 1.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 2.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 1.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.5 | 1.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.5 | 1.5 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.5 | 1.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.5 | 1.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 1.5 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.5 | 0.5 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.5 | 1.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.5 | 3.8 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.5 | 0.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.5 | 0.9 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.5 | 1.4 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.5 | 3.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 2.8 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.5 | 1.4 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.5 | 3.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.5 | 0.9 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.5 | 1.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 1.8 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.5 | 1.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.5 | 0.5 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.5 | 0.5 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.5 | 1.4 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.5 | 0.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.4 | 1.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 2.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 1.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.4 | 2.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.4 | 2.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 0.4 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.4 | 1.3 | GO:0019042 | viral latency(GO:0019042) |
0.4 | 1.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 4.8 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.4 | 0.4 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.4 | 1.3 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.4 | 0.4 | GO:0036166 | phenotypic switching(GO:0036166) |
0.4 | 1.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.4 | 1.7 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.4 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.4 | 0.4 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.4 | 0.8 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.4 | 3.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 1.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 1.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 3.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.4 | 1.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 1.3 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 1.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 0.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 1.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 0.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.4 | 1.2 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.4 | 0.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.4 | 2.1 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.4 | 1.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 2.0 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.4 | 3.7 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.4 | 2.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.4 | 1.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.4 | 1.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 1.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 1.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 7.5 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.4 | 1.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.4 | 1.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.4 | 0.4 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.4 | 2.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.4 | 1.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.4 | 2.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 2.7 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.4 | 1.2 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.4 | 0.4 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.4 | 0.8 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.4 | 2.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 2.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.4 | 1.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 0.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.4 | 1.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 1.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.4 | 0.8 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 1.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.4 | 0.4 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.4 | 0.8 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.4 | 1.1 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.4 | 4.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 0.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 3.8 | GO:0018904 | ether metabolic process(GO:0018904) |
0.4 | 1.9 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 1.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 0.7 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.4 | 1.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 3.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 1.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.4 | 1.1 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 0.7 | GO:0071675 | positive regulation of macrophage chemotaxis(GO:0010759) regulation of mononuclear cell migration(GO:0071675) |
0.4 | 0.7 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.4 | 1.5 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.4 | 0.4 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.4 | 5.9 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.4 | 0.4 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.4 | 3.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.4 | 0.4 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.4 | 0.4 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.4 | 1.1 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.4 | 1.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.4 | 1.8 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
0.4 | 1.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 0.7 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.4 | 2.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 1.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.4 | 0.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 0.4 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.4 | 1.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.4 | 1.1 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.4 | 2.1 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 0.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.4 | 1.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.4 | 0.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 0.7 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.4 | 2.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 1.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.4 | 2.1 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.3 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.3 | 1.4 | GO:0032347 | regulation of aldosterone biosynthetic process(GO:0032347) |
0.3 | 9.7 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.3 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 3.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 1.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 1.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 0.7 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 0.3 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.3 | 1.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 4.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 2.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.3 | 2.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 0.7 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.3 | 0.3 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.3 | 2.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 0.7 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.3 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 1.0 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 0.7 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.3 | 3.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 0.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 1.3 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.3 | 0.3 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.3 | 0.7 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 3.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 3.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.3 | 1.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 1.0 | GO:0043486 | histone exchange(GO:0043486) |
0.3 | 4.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 1.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 2.6 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.3 | 1.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 0.3 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.3 | 1.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 1.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 1.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 1.6 | GO:0001660 | fever generation(GO:0001660) |
0.3 | 1.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 0.7 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 0.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 1.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 2.0 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.3 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 2.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.3 | 0.3 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.3 | 1.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.3 | 1.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 1.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.3 | 1.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 2.9 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 1.9 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.3 | 0.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 1.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.3 | 0.9 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.3 | 1.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 2.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 0.9 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.3 | 1.5 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.3 | 0.6 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.3 | 0.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 0.6 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 0.9 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 0.9 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.3 | 1.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.3 | 4.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.3 | 0.9 | GO:0034214 | protein hexamerization(GO:0034214) |
0.3 | 3.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.3 | 0.6 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.3 | 0.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 0.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.3 | 0.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 2.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 2.4 | GO:0006414 | translational elongation(GO:0006414) |
0.3 | 1.5 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.3 | 2.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 | 0.6 | GO:0019081 | viral translation(GO:0019081) |
0.3 | 0.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 1.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 3.6 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.3 | 1.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 0.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 1.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.3 | 1.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.3 | 0.9 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 2.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 0.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 0.6 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.3 | 2.1 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 2.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 1.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 0.6 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 3.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 0.6 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 1.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 1.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.3 | 0.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 0.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 0.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 0.9 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.3 | 0.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.3 | 0.3 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.3 | 0.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 0.9 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.3 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 0.6 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.3 | 2.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 1.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 1.7 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.3 | 0.6 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.3 | 1.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 0.6 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 0.6 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.3 | 0.8 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 1.4 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 1.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 1.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.3 | 0.3 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 1.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.3 | 0.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 1.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 0.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 1.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.3 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.3 | 1.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 | 0.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.3 | 0.8 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 0.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 1.4 | GO:0021561 | facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) |
0.3 | 1.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.3 | 0.8 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.3 | 0.3 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 1.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 1.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 3.0 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.3 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 0.3 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.3 | 1.1 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.3 | 0.5 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.3 | 3.2 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.3 | 0.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.3 | 0.8 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.3 | 1.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.3 | 1.6 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 1.9 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.3 | 1.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.3 | 1.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.3 | 0.5 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 1.9 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.3 | 0.8 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) |
0.3 | 1.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 0.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 0.8 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.3 | 1.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 3.6 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.3 | 0.3 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.3 | 0.3 | GO:2000508 | dendritic cell chemotaxis(GO:0002407) regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.3 | 1.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 1.0 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.3 | 1.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 1.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 0.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.3 | 0.3 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.3 | 1.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.3 | 1.8 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.3 | 3.8 | GO:0001945 | lymph vessel development(GO:0001945) |
0.3 | 2.8 | GO:0033622 | integrin activation(GO:0033622) |
0.3 | 1.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 0.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 0.8 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 2.0 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.3 | 1.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.8 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.3 | 1.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 0.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 0.5 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 1.5 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.2 | 1.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 2.0 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 1.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 1.2 | GO:0001840 | neural plate development(GO:0001840) |
0.2 | 1.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 2.0 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.5 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.2 | 2.7 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.5 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 2.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.7 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.2 | 0.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 1.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 4.1 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.2 | 0.5 | GO:0090382 | phagosome maturation(GO:0090382) |
0.2 | 1.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.7 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 1.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 1.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 1.7 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.7 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 1.9 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.2 | 3.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.0 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 0.5 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.2 | 0.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 1.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 2.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 1.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.2 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.2 | 1.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.2 | 0.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 1.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 1.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.9 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 1.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.7 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 1.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 0.5 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.2 | 0.5 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 0.7 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 2.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.2 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.2 | 0.9 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.2 | 0.9 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 1.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 1.3 | GO:0006266 | DNA ligation(GO:0006266) |
0.2 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 1.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 2.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 2.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 1.5 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.2 | 0.9 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 0.9 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 3.3 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.2 | 1.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 2.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 2.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.2 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 1.9 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.2 | 2.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.6 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 1.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 3.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.6 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 0.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.8 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.6 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 1.3 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.2 | 0.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 2.9 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.2 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 0.8 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.6 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 1.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 1.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 0.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 0.6 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 0.2 | GO:0021546 | rhombomere development(GO:0021546) |
0.2 | 1.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 1.6 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.2 | 0.4 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.2 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 0.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.2 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.2 | 0.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 0.8 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 0.4 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 2.0 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.2 | 0.2 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.2 | 0.6 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 1.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 0.8 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.4 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.2 | 1.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.2 | 0.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.8 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.2 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.2 | 0.6 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.2 | 0.6 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 0.6 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.2 | 0.6 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 1.9 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.2 | 0.4 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 0.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 0.4 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.2 | 0.4 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 0.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 0.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.2 | 0.8 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 0.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 2.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.2 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 1.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.8 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.2 | 1.5 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 0.4 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.2 | 0.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.6 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.2 | 0.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 1.3 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.2 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.4 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 0.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 1.7 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 0.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 1.1 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.2 | 1.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 1.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.2 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.2 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.2 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.2 | 1.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.7 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 0.2 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 1.5 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.2 | 4.9 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.2 | 0.7 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.2 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 0.2 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.2 | 0.5 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.2 | 0.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 0.2 | GO:0010042 | response to manganese ion(GO:0010042) |
0.2 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 0.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 4.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.7 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.7 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.9 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 0.2 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 1.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 2.1 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 0.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 0.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.3 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 0.9 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 3.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 1.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 0.7 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 1.0 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.5 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 1.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.7 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.2 | 0.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 1.3 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.2 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 0.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 0.2 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.2 | 0.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.2 | 1.2 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.2 | 1.7 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.2 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.3 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 1.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.7 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 0.2 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.2 | 0.5 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.2 | 0.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 1.5 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 1.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 1.3 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.2 | 1.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.3 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.6 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.2 | 0.6 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.2 | 0.6 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.8 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 0.6 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
0.2 | 0.2 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.2 | 0.3 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 0.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 0.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.3 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.2 | 2.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.2 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.2 | 0.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 0.2 | GO:0045010 | actin nucleation(GO:0045010) |
0.2 | 0.5 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.2 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 4.6 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 0.5 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.2 | 0.6 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 0.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 0.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 1.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.5 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.2 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.4 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.9 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 0.1 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 1.8 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.1 | 0.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 2.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 1.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.7 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.9 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.1 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 2.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.9 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.4 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.7 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 1.1 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 0.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 3.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.1 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 1.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 3.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.1 | GO:0051647 | nucleus localization(GO:0051647) |
0.1 | 0.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 2.2 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 1.0 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 1.4 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 1.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 1.4 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 1.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.3 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.7 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 | 1.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 2.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.3 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 2.0 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.8 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.1 | 2.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.4 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.1 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 1.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.4 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.1 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 1.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 1.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 1.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.5 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.8 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.5 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.1 | 1.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 2.1 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 1.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 1.0 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.9 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 2.1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.7 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 3.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.4 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 2.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.6 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.1 | 0.2 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.7 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.8 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 1.1 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 1.1 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.1 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.4 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 4.2 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 3.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.6 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 1.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.2 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.3 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.5 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.2 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.9 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 1.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 2.3 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 1.2 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.9 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.2 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.1 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.2 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.1 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.5 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.2 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.4 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.1 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.1 | 0.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 1.1 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.2 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.1 | 0.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.4 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.2 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.3 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.1 | 1.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 2.0 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 2.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.4 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 1.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.3 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 0.5 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.2 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 3.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.9 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.4 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.1 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.1 | 0.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 1.1 | GO:0007492 | endoderm development(GO:0007492) |
0.1 | 0.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.2 | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.4 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.3 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.1 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.7 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.2 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.6 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.4 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.5 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 1.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 1.0 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.2 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.1 | 0.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 2.9 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.4 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.1 | GO:0071726 | response to bacterial lipoprotein(GO:0032493) response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.8 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.3 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.3 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.5 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.5 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.8 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.9 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.4 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.1 | 0.4 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.3 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 0.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.4 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 0.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.9 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.1 | GO:0048793 | pronephros development(GO:0048793) |
0.1 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.5 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.1 | 0.7 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.4 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.1 | GO:0044743 | intracellular protein transmembrane import(GO:0044743) |
0.1 | 0.6 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.1 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.4 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.3 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.1 | 0.1 | GO:0060872 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.1 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.1 | 0.3 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.1 | 0.1 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 5.0 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 1.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 1.3 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 1.1 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.6 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.6 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 1.1 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.1 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.3 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.1 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.4 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.1 | 0.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 1.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.3 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.3 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.3 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 3.3 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.1 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.1 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.1 | 0.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.9 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 1.8 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.3 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.3 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.1 | 0.1 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.2 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.1 | 0.4 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.1 | GO:0072283 | metanephric renal vesicle morphogenesis(GO:0072283) |
0.1 | 0.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.9 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.3 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.1 | 2.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.1 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.8 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.4 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.8 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:0033685 | regulation of luteinizing hormone secretion(GO:0033684) negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 1.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.8 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.7 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.1 | 0.1 | GO:0043038 | amino acid activation(GO:0043038) |
0.1 | 3.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 1.4 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.1 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.1 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.6 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.3 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 0.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.2 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.1 | 0.1 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.1 | 0.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.0 | 0.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.1 | GO:0031100 | organ regeneration(GO:0031100) |
0.0 | 0.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.3 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.0 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.0 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.0 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.0 | 0.8 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.1 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.1 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.2 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.0 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.0 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.0 | 1.1 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 1.1 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.0 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.0 | GO:0035766 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.0 | 0.0 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.0 | GO:0051580 | regulation of neurotransmitter uptake(GO:0051580) |
0.0 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.0 | 0.7 | GO:0030814 | regulation of cAMP metabolic process(GO:0030814) |
0.0 | 0.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.5 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.3 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.0 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.0 | GO:0032528 | microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 1.7 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.0 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
0.0 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.0 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.0 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.3 | GO:1903510 | mucopolysaccharide metabolic process(GO:1903510) |
0.0 | 0.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.0 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.0 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.1 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 0.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.0 | 0.1 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.0 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.0 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.0 | 0.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.0 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.0 | 0.0 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.1 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.1 | GO:0097443 | sorting endosome(GO:0097443) |
1.2 | 7.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.9 | 8.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.8 | 2.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.8 | 0.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.8 | 2.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.7 | 2.1 | GO:0031417 | NatC complex(GO:0031417) |
0.7 | 2.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.7 | 3.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 2.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.6 | 1.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 6.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.6 | 1.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.6 | 1.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.6 | 4.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 1.6 | GO:0031523 | Myb complex(GO:0031523) |
0.5 | 2.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.5 | 1.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.5 | 2.7 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 1.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 0.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 2.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.5 | 0.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.5 | 3.1 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 2.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 1.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 4.0 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 1.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 3.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 1.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.5 | 1.4 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 1.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.5 | 1.8 | GO:0032437 | cuticular plate(GO:0032437) |
0.4 | 4.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 1.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 4.9 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 3.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.4 | 1.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 1.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 1.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 1.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.4 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 1.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 4.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 0.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.4 | 0.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.4 | 3.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 2.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.4 | 0.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 1.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.4 | 1.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 1.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.4 | 2.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.4 | 1.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.4 | 1.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 1.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 1.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 1.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 1.9 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.4 | 1.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.4 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 1.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 1.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 2.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 2.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 1.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 1.8 | GO:0005767 | secondary lysosome(GO:0005767) |
0.4 | 1.8 | GO:0000243 | commitment complex(GO:0000243) |
0.3 | 1.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 5.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.3 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 1.0 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 3.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 1.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 2.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 1.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 1.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 3.6 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 2.3 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.3 | 1.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 1.9 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 2.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 4.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 2.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 5.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 3.9 | GO:0000974 | Prp19 complex(GO:0000974) |
0.3 | 2.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 3.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 0.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 1.2 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 0.9 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 2.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 2.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 0.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 7.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 3.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 0.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 1.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 2.0 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.3 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 2.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.3 | 0.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 1.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 1.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 0.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.3 | 1.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 4.1 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.3 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 4.3 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 2.2 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 0.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.3 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.3 | 0.5 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 0.8 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 1.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 4.0 | GO:0002102 | podosome(GO:0002102) |
0.2 | 2.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 4.9 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 1.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 1.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 1.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 0.7 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 1.0 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 6.9 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 2.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 1.7 | GO:0000801 | central element(GO:0000801) |
0.2 | 11.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.9 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 2.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 1.4 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 0.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 1.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 1.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.9 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 1.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 0.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 1.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 1.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 0.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 3.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.1 | GO:0005818 | aster(GO:0005818) |
0.2 | 0.6 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.2 | 0.8 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 0.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 1.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.6 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 1.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 1.0 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 1.0 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 3.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 4.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 17.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 5.1 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 1.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 1.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.2 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.7 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 1.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 1.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 2.9 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 1.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 2.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.7 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 1.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 5.8 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 1.8 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 0.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 3.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 13.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 0.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 1.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 3.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 10.4 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.2 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 1.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 3.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 1.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 1.7 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 1.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 2.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.4 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 2.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 1.5 | GO:0001741 | XY body(GO:0001741) |
0.1 | 1.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.1 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.7 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 5.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.4 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 1.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 4.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 10.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 1.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 2.4 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 1.5 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.1 | 0.5 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.6 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 1.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 2.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.2 | GO:0071014 | U2-type post-mRNA release spliceosomal complex(GO:0071008) post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 5.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.2 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 5.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 2.3 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 1.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.3 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.7 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 2.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 5.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.8 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 4.6 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 1.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.3 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 2.1 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.3 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 2.9 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 3.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.0 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 2.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.6 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 4.7 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.7 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 2.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 2.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 3.4 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 3.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.6 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 16.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 7.4 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.1 | 0.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 1.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.6 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.8 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 1.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 4.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 1.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 1.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 3.5 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 2.8 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.4 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 1.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 1.3 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 13.9 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 2.7 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.0 | 0.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 35.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 1.6 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.3 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.0 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.3 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.6 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.4 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 1.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.0 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 1.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.9 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 1.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.0 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 29.9 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 0.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.1 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 26.0 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.7 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.2 | 7.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.2 | 3.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.2 | 3.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.2 | 3.5 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
1.0 | 3.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.0 | 2.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.9 | 2.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.9 | 2.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.9 | 4.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.9 | 2.8 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.9 | 2.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.9 | 1.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.9 | 3.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.9 | 8.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.9 | 8.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.9 | 0.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.9 | 3.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.8 | 2.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.8 | 0.8 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.8 | 5.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.8 | 2.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.8 | 2.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.8 | 1.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.8 | 2.3 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 3.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 4.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.7 | 4.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 2.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.7 | 2.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.7 | 3.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.7 | 3.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.7 | 2.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.6 | 3.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.6 | 3.7 | GO:0035473 | lipase binding(GO:0035473) |
0.6 | 1.8 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.6 | 1.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.6 | 0.6 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.6 | 1.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 2.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 1.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.6 | 1.8 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.6 | 2.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.6 | 3.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.6 | 1.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 1.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.6 | 1.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.5 | 2.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.5 | 6.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 2.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 0.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 1.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 2.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.5 | 6.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 2.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.5 | 2.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 0.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.5 | 1.5 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.5 | 2.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.5 | 1.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.5 | 1.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 2.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 3.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 1.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.5 | 1.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.5 | 1.4 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.5 | 1.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.5 | 0.5 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.5 | 4.7 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.5 | 1.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 1.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 1.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 1.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 2.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 1.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 3.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 1.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 3.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 0.9 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.4 | 1.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 1.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 1.8 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 5.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 1.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.4 | 2.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 0.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 1.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 3.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 2.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 0.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.4 | 1.3 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 1.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 1.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 2.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.4 | 1.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 3.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 1.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 1.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 3.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.4 | 1.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.4 | 0.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.4 | 0.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 2.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 1.9 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.4 | 2.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.4 | 1.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 1.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 1.1 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 3.7 | GO:0015266 | protein channel activity(GO:0015266) |
0.4 | 0.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.4 | 0.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.4 | 2.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 4.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 1.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 1.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.4 | 10.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.4 | 1.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 1.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 1.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 0.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.4 | 3.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 1.8 | GO:0052760 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.4 | 2.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.3 | 1.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 2.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 0.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 4.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 6.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 4.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 2.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 1.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 2.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 3.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 0.6 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 2.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 0.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 0.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.3 | 0.3 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 3.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.3 | 1.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 0.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 0.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 0.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 1.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 1.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.3 | 2.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 6.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 1.5 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.3 | 1.2 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 1.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 2.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.3 | 1.2 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 3.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 2.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 3.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 0.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 1.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 0.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.3 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 2.8 | GO:0017069 | snRNA binding(GO:0017069) |
0.3 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 1.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 1.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 2.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 2.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 1.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 0.6 | GO:0035877 | death effector domain binding(GO:0035877) |
0.3 | 0.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.3 | 0.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 0.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 1.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 1.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 0.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 1.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 0.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 1.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.3 | 1.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 1.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 0.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 0.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 1.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 1.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 0.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 0.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 3.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 1.3 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 1.8 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 0.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 0.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 0.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 0.8 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 1.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 0.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 2.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.3 | 2.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.3 | 0.8 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 1.0 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 0.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.3 | 0.8 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 0.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 2.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 1.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 1.0 | GO:0052629 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 11.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 2.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 2.1 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 6.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 1.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 1.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 0.9 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 3.3 | GO:0016918 | retinal binding(GO:0016918) |
0.2 | 0.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 1.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 1.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.2 | 1.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 4.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 3.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.9 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.2 | 6.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 1.6 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 1.6 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.2 | 2.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 2.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 2.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 1.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 0.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 0.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 1.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 0.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 1.5 | GO:0034534 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 0.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 0.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.2 | 0.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 2.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 1.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.8 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 11.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 3.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 5.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.8 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 5.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 1.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 2.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 2.4 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 1.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.2 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.2 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 1.9 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 1.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 3.3 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 1.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 3.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 1.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 1.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 3.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 1.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 2.4 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.2 | 2.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 10.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 1.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 6.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 0.4 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
0.2 | 0.5 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 6.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 2.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 2.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 2.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 1.2 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 1.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 5.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.2 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.2 | 0.4 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 0.9 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.2 | 3.3 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 32.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.2 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.2 | 1.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 4.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.3 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 2.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 3.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 2.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 3.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 2.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 0.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 0.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 0.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 1.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 3.3 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 1.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 1.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.6 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 0.9 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.2 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.2 | 0.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.9 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 2.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 1.0 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 2.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.4 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.1 | GO:0030351 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.1 | 1.1 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 2.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.7 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 1.1 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 1.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 1.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 2.7 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 1.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 1.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.1 | GO:0051379 | epinephrine binding(GO:0051379) |
0.1 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 2.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.6 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.9 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 1.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.5 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 2.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 2.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.3 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 3.7 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 1.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 3.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 2.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.2 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 2.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 2.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 6.5 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.3 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.9 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.9 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 1.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 1.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 3.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 1.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 3.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.5 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.1 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.1 | 0.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 1.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 5.1 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 8.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 6.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 8.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 2.7 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.4 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 1.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 4.7 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 3.3 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.9 | GO:0004601 | peroxidase activity(GO:0004601) |
0.1 | 1.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 1.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.8 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 2.6 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 2.0 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 4.9 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 4.8 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.8 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 1.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.1 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 1.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 1.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 2.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 1.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 1.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.3 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 0.3 | GO:0034778 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 1.4 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 1.8 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.8 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 1.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.1 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.3 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.9 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 7.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 0.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 1.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.2 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.4 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 2.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 2.8 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 0.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:1990188 | euchromatin binding(GO:1990188) |
0.0 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.0 | 0.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 1.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.0 | GO:1901338 | catecholamine binding(GO:1901338) |
0.0 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 4.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 5.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 1.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.0 | GO:0090484 | drug transporter activity(GO:0090484) |
0.0 | 1.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.0 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.0 | 0.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.9 | GO:0005550 | pheromone binding(GO:0005550) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 6.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.7 | 1.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 1.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.6 | 0.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 16.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 3.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 1.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.5 | 3.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 4.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.4 | 14.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 2.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 2.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 2.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 16.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 7.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 4.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 13.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 9.4 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 22.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 8.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 6.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 1.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 2.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 4.9 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 7.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 0.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 1.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 1.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 1.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 1.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 11.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 1.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 0.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 4.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 2.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 13.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 3.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 6.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 4.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 3.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 4.3 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 1.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 6.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 2.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 2.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 3.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 2.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 1.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 22.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 2.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 3.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 2.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 2.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 3.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 4.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 1.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 3.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 2.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 3.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 4.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 2.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 3.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.2 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 2.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 2.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 2.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 8.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 2.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 7.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.7 | 6.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.7 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.6 | 8.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.6 | 11.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.6 | 2.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.6 | 7.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.5 | 4.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 4.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 0.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.5 | 1.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 4.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 3.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 0.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.4 | 4.9 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.4 | 2.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 1.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 2.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.4 | 4.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 0.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 0.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.4 | 5.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 8.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 2.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.3 | 5.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 2.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 8.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 0.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 2.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 3.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 6.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 1.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 0.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 3.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 0.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.3 | 0.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 1.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 11.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 3.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 6.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 2.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 2.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 2.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 1.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 1.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 5.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 0.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 4.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 10.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 6.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 2.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 5.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.2 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 0.6 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 1.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 3.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 2.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 0.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 5.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 3.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 0.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 2.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 1.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 1.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 7.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 1.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 1.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 0.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 3.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 0.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 1.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 1.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 1.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 2.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 2.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 4.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 2.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 10.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 4.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 2.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 4.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 2.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 1.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 10.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 4.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 2.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.4 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 0.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 2.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 2.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.5 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 0.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.4 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 3.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 2.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 3.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 1.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 1.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 3.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 4.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 2.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 5.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 2.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.8 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 1.6 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.3 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.1 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.5 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.0 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.0 | 0.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |